Setback for an Alzheimer's disease vaccine: lessons learned

Neurology. 2003 Jul 8;61(1):7-8. doi: 10.1212/wnl.61.1.7.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Alzheimer Disease / immunology*
  • Alzheimer Disease / pathology
  • Alzheimer Disease / prevention & control*
  • Alzheimer Vaccines / adverse effects*
  • Amyloid beta-Peptides / antagonists & inhibitors
  • Amyloid beta-Peptides / immunology*
  • Animals
  • Blood-Brain Barrier / immunology
  • Cerebrospinal Fluid Proteins / cerebrospinal fluid
  • Cognition Disorders / immunology
  • Disease Models, Animal
  • Disease Progression
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / cerebrospinal fluid
  • Immunotherapy / adverse effects
  • Macrophages / immunology
  • Macrophages / pathology
  • Meningoencephalitis / etiology*
  • Meningoencephalitis / immunology
  • Mice
  • Neurofibrillary Tangles / pathology
  • Plaque, Amyloid / immunology
  • Plaque, Amyloid / pathology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology
  • Treatment Outcome

Substances

  • Alzheimer Vaccines
  • Amyloid beta-Peptides
  • Cerebrospinal Fluid Proteins
  • Immunoglobulin G